Standard and Interpretation
Recommendations of diagnosis and treatment of gout in China
Xu Dong, Zhu Xiaoxia, Zeng Xuejun, Zou Hejian, Gu Jieruo, Zhou Jingguo, Zeng Xiaofeng, Zhao Yan, on behalf of Chinese Association of Gout Study of Rheumatology and Immunology Physicians Committee of Chinese Medical Doctor Association
Published 2020-06-01
Cite as Chin J Intern Med, 2020, 59(6): 421-426. DOI: 10.3760/cma.j.cn112138-20200327-00306
Abstract
Gout is a crystal associated arthritis caused by monosodium urate (MSU) accumulating in joint, and it belongs to metabolic rheumatic disease. In China, gout is common but it is insufficient for education of standardized diagnosis and treatment for gout. Based on the evidence and guidelines from China and other countries, Chinese gout Collaborative Research Group developed standardization of diagnosis and treatment of gout in China. The purpose is to standardize the methods for diagnosis of gout, treatment opportunity and strategies in order to reduce misdiagnosis, missed diagnosis and irreversible damage.
Key words:
Gout; Diagnosis; Therapy
Contributor Information
Xu Dong
Department of Rheumatology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, National Clinical Research Center for Dermatologic and Immunologic Diseases, Beijing 100730, China
Zhu Xiaoxia
Division of Rheumatology, Huashan Hospital, Fudan University, Shanghai 200040, China
Zeng Xuejun
Department of General Practice, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China
Zou Hejian
Division of Rheumatology, Huashan Hospital, Fudan University, Shanghai 200040, China
Gu Jieruo
Department of Rheumatology and Immunology, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China
Zhou Jingguo
Department of Rheumatology and Immunology, The First Affiliated Hospital of Chengdu Medical College, Chengdu 610500, China
Zeng Xiaofeng
Department of Rheumatology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, National Clinical Research Center for Dermatologic and Immunologic Diseases, Beijing 100730, China
Zhao Yan
Department of Rheumatology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, National Clinical Research Center for Dermatologic and Immunologic Diseases, Beijing 100730, China
on behalf of Chinese Association of Gout Study of Rheumatology and Immunology Physicians Committee of Chinese Medical Doctor Association
